Literature DB >> 795575

Determination of anti-DNA antibodies by a modified 125I-labelled DNA-binding test. Elimination of non-specific binding of DNA to non-immunoglobulin basic proteins by using an anionic detergent.

S Izui, P H Lambert, P A Miescher.   

Abstract

A modified 125I-labelled DNA-binding test was developed. By using an anionic detergent, 0-025% sodium dodecyl sulphate, the non-specific binding of DNA by basic proteins was completely eliminated, while the specific binding of DNA by anti-DNA antibodies was not interfered with. The level of DNA-binding activity in normal human sera was decreased in the modified DNA-binding test, while its sensitivity was similar to that of the Farr assay in presence of sera from SLE patients.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 795575      PMCID: PMC1540975     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  16 in total

1.  Immunology of DNA. I. The influence of reaction conditions on the Farr assay as used for the detection of anti-ds DNA.

Authors:  L A Aarden; F Lakmaker; T E Feltkamp
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

2.  Estimation of the double-helical content in various single-stranded nucleic acids by treatment with a single strand-specific nuclease.

Authors:  K Shishido; T Ando
Journal:  Biochim Biophys Acta       Date:  1972-12-22

3.  Nucleic acid antibodies in African trypanosomiasis: studies in Rhesus monkeys and man.

Authors:  H B Lindsley; S Kysela; A D Steinberg
Journal:  J Immunol       Date:  1974-12       Impact factor: 5.422

4.  Deoxyribonucleic acid antibody: a method to detect its primary interaction with deoxyribonucleic acid.

Authors:  R T Wold; F E Young; E M Tan; R S Farr
Journal:  Science       Date:  1968-08-23       Impact factor: 47.728

5.  Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus.

Authors:  E M Tan; P H Schur; R I Carr; H G Kunkel
Journal:  J Clin Invest       Date:  1966-11       Impact factor: 14.808

6.  Anti-DNA activity in systemic lupus erythematosus. A diagnostic and therapeutic guide.

Authors:  G R Hughes; S A Cohen; C L Christian
Journal:  Ann Rheum Dis       Date:  1971-05       Impact factor: 19.103

7.  Proteins from human cerebrospinal fluid: binding with nucleic acids.

Authors:  H Kubinski; M Javid
Journal:  Science       Date:  1973-10-19       Impact factor: 47.728

8.  The occurrence of single-stranded DNA in the serum of patients with systemic lupus erythematosus and other diseases.

Authors:  D Koffler; V Agnello; R Winchester; H G Kunkel
Journal:  J Clin Invest       Date:  1973-01       Impact factor: 14.808

9.  Immunological studies concerning the nephritis of systemic lupus erythematosus.

Authors:  D Koffler; P H Schur; H G Kunkel
Journal:  J Exp Med       Date:  1967-10-01       Impact factor: 14.307

10.  Release of DNA in circulating blood and induction of anti-DNA antibodies after injection of bacterial lipopolysaccharides.

Authors:  G J Fournié; P H Lambert; P A Meischer
Journal:  J Exp Med       Date:  1974-11-01       Impact factor: 14.307

View more
  37 in total

1.  Prolonged circulation of immune complexes due to various altered immune functions contributes to nephritis in MRL/lpr mice.

Authors:  N A Granholm; T Cavallo
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

2.  Accelerated (proliferative) lupus nephritis.

Authors:  T Cavallo; N A Granholm
Journal:  Am J Pathol       Date:  1990-12       Impact factor: 4.307

3.  Lipopolysaccharide from gram-negative bacteria enhances polyclonal B cell activation and exacerbates nephritis in MRL/lpr mice.

Authors:  T Cavallo; N A Granholm
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

4.  Drug-combination therapy of rheumatoid arthritis.

Authors:  P A Miescher; H Favre; R Lemoine; P Tamagnini
Journal:  Springer Semin Immunopathol       Date:  1998

5.  Repeated exposure to bacterial lipopolysaccharide interferes with disposal of pathogenic immune complexes in mice.

Authors:  T Cavallo; N A Granholm
Journal:  Clin Exp Immunol       Date:  1990-02       Impact factor: 4.330

6.  Bacterial lipopolysaccharide transforms mesangial into proliferative lupus nephritis without interfering with processing of pathogenic immune complexes in NZB/W mice.

Authors:  T Cavallo; N A Granholm
Journal:  Am J Pathol       Date:  1990-10       Impact factor: 4.307

7.  Polyclonal B cell activation, circulating immune complexes and autoimmunity in human american visceral leishmaniasis.

Authors:  B Galvão-Castro; J A Sá Ferreira; K F Marzochi; M C Marzochi; S G Coutinho; P H Lambert
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

8.  Combined steroid-cyclosporin treatment of chronic autoimmune diseases. Clinical results and assessment of nephrotoxicity by renal biopsy.

Authors:  P A Miescher; H Favre; F Chatelanat; M J Mihatsch
Journal:  Klin Wochenschr       Date:  1987-08-03

9.  Measurement of serum DNA binding in chronic active hepatitis and systemic lupus erythematosus using the Farr assay.

Authors:  K M Pollard; R Steele; S Hogg; J Webb
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

10.  Antigenic structure of DNA: relatively high inhibitory activity of di- and trideoxyribonucleotide derived from DNase digest on the interaction of thermally denatured DNA with systemic lupus erythematosus sera.

Authors:  M Kashimura; A Wakizaka; K Kurosaka; E Okuhara; T Akihama; A B Miura; A Shibata
Journal:  Clin Exp Immunol       Date:  1981-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.